Risk Assessment for Cardiovascular Disease Using the Framingham Risk Score and Globorisk Score Among Newly Diagnosed Metabolic Syndrome Patients.
Syed Omair AdilFareed UddinKamarul Imran MusaAsima KhanAreebah ShakeelKashif ShafiqueMd Asiful IslamPublished in: International journal of general medicine (2023)
The outcome of both CVD risk scores predicted moderate-to-high risk of CVD in 10-years in almost half of the newly diagnosed patients with MetS. In particular, the risk of development of CVD in 10-years in newly diagnosed MetS is higher with increasing age, in male gender, and current smokers.